首頁(yè) 資訊 Elevance推出體重管理計(jì)劃，包括GLP

Elevance推出體重管理計(jì)劃，包括GLP

來(lái)源：泰然健康網(wǎng) 時(shí)間：2024年12月17日 10:39

Listen to the article

聽(tīng)這篇文章

This audio is auto-generated. Please let us know if you have feedback.

此音頻是自動(dòng)生成的。如果您有反饋，請(qǐng)告知我們。

Elevance Health is launching a digital weight management program as interest picks up around new medications for weight loss called GLP-1s.

Elevation Health正在啟動(dòng)一項(xiàng)數(shù)字體重管理計(jì)劃，人們對(duì)稱為GLP-1s的新型減肥藥物越來(lái)越感興趣。

The program announced Monday will be available in the spring for employer clients of Elevance’s pharmacy benefit manager CarelonRx. Users who are prescribed GLP-1 drugs will have access to medication management support and a digital companion module, according to the release.

周一宣布的該計(jì)劃將于春季為Elevation藥房福利管理公司CarelonRx的雇主客戶提供。根據(jù)該版本，處方GLP-1藥物的用戶將獲得藥物管理支持和數(shù)字伴侶模塊。

Elevance joins a growing list of insurers expanding their weight management offerings after demand for GLP-1 drugs has soared over the past year.

在過(guò)去一年對(duì)GLP-1藥物的需求激增后，Elevation加入了不斷擴(kuò)大其體重管理產(chǎn)品的保險(xiǎn)公司名單。

Utilization of GLP-1s, short for glucagon-like peptide 1 agonists, has been building as the drugs, originally approved for diabetes, are used more frequently for weight loss.

GLP-1s是胰高血糖素樣肽1激動(dòng)劑的縮寫，隨著最初被批準(zhǔn)用于糖尿病的藥物更頻繁地用于減肥，GLP-1s的利用一直在建設(shè)中。

Heightened demand for GLP-1s, which include Novo Nordisk’s Ozempic and Wegovy, have created a worldwide shortage of the drugs, despite their hefty price tags. List prices for Wegovy and Ozempic can hover around $1,000, although net prices — negotiated by companies in part through PBMs — can be lower..

對(duì)GLP-1（包括諾和諾德的Ozempic和Wegovy）的需求增加，導(dǎo)致全球藥品短缺，盡管價(jià)格昂貴。Wegovy和Ozempic的標(biāo)價(jià)可能徘徊在1000美元左右，盡管公司部分通過(guò)PBMs協(xié)商的凈價(jià)可能更低。。

Insurers have been pulling back on coverage of the drugs to rein in costs as demand surges. However, payers’ own PBMs are seeing benefits from rising demand for GLP-1s. Last year, insurers including Elevance said they generated notable revenue from GLP-1s in their pharmacy arms.

隨著需求激增，保險(xiǎn)公司一直在縮減藥品的保險(xiǎn)范圍，以控制成本。然而，付款人自己的PBM從對(duì)GLP-1的需求上升中受益。去年，包括Elevation在內(nèi)的保險(xiǎn)公司表示，他們從制藥部門的GLP-1s中獲得了可觀的收入。

Elevance’s new program will provide coaching and tools to help customers monitor weight loss, along with screenings for behavioral health and social needs, according to the insurer.

據(jù)該保險(xiǎn)公司稱，Elevation的新計(jì)劃將提供指導(dǎo)和工具，幫助客戶監(jiān)測(cè)體重減輕情況，同時(shí)篩查行為健康和社會(huì)需求。

Cigna and UnitedHealth have also announced similar programs in a bid to capitalize on GLP-1 furor.

信諾（Cigna）和聯(lián)合健康（UnitedHealth）也宣布了類似的計(jì)劃，以利用GLP-1的熱潮。

Cigna’s health services arm Evernorth — which includes its PBM Express Scripts — released its chronic condition management program dubbed EncircleRx last year after Evernorth saw an increase in GLP-1 utilization.

信諾的健康服務(wù)部門Evernorth（包括其PBM Express腳本）去年發(fā)布了名為EncircleRx的慢性病管理計(jì)劃，此前Evernorth的GLP-1利用率有所提高。

UnitedHealth released its weight management program Optum Rx Weight Engage in January.

UnitedHealth于1月份發(fā)布了其體重管理計(jì)劃Optum Rx weight Engage。

Trends shaping the business of health insurance in 2024

2024年健康保險(xiǎn)業(yè)務(wù)發(fā)展趨勢(shì)

GLP-1s for weight loss leave employers in a bind over coverage

用于減肥的GLP-1s讓雇主在覆蓋范圍之外陷入困境

Oct. 13, 2023

2023年10月13日

網(wǎng)址: Elevance推出體重管理計(jì)劃，包括GLP http://www.u1s5d6.cn/newsview592903.html